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Independent action of prostaglandins and kinins on vasopressin-
stimulated water flow. The kallikrein-kinin and the prostaglandin sys-
tems are both important modifiers of vasopressin action. This study
examines whether the systems are dependent on one another for their
action. Four groups of toad hemibladders were examined. In groups 1
and 2 animals the endogenous prostaglandin system was inhibited.
Inhibition of kallikrein by aprotinin caused vasopressin-stimulated
water flow to increase further (24.8 4.9 to 34.5 4.8 s1/min) while
potentiation of kinins by captropril caused vasopressin-stimulated
water flow to decrease (45 6.3 to 30.5 5.4 t1Imin). In groups 3 and
4 endogenous kallikrein was inhibited by aprotinin. The addition of
prostaglandin E2 caused vasopressin-stimulated water flow to decrease
(17.5 2.7 to 5.71 1.0 dImin) while the inhibition of endogenous
prostaglandins caused vasopressin-stimulated water flow to increase
(26.7 3.4 to 39.2 3.5 sl/min). Thus, the inhibitory effects of
prostaglandins and kinins on vasopressin-stimulated water flow are
independent of one another.
Action independante des prostaglandines et kinines sur le flux hydrique
stimulé par Ia vasopressine. Les systèmes kallikréine-kinine et
prostaglandines sont tous deux d'importants modulateurs de l'action de
Ia vasopressine. Cette étude recherche si ces systèmes sont dépendants
entre eux dans leur action. Quatre groupes d'hëmi-vessies de crapaud
ont été examines. Chez les animaux des groupes 1 et 2, le système des
prostaglandines endogenes a eté inhibé. L'inhibition de Ia kallikréine
par l'aprotinine a eu pour effet d'augmenter encore le flux hydrique
stimulé par la vasopressine (24,8 4,9 a 34,5 4,8 id/mm), tandis que
La potentialisation des kinines par le captopril diminuait Ic flux hydrique
stimulé par la vasopressine (45 6,3 6 30,5 5,4 .d/min). Dans les
groupes 3 et 4, la kallikréine endogène était inhibée par l'aprotinine.
L'addition de prostaglandine E2 diminuait le flux d'eau stimulé par La
vasopressine (17,5 2,7 a 5,71 1,0 p1/mm), alors que l'inhibition des
prostaglandines endogenes élevait le flux hydrique stimulC par la
vasopressine (26,7 3,4 a 39,2 3,5 p1/mm). Ainsi, les effets
inhibiteurs des prostaglandines et des kinines sur le flux d'eau stimulé
par la vasopressine sont indCpendants l'un de I'autre.
A close relationship between the renal prostaglandin system
and the renal kallikrein-kinin system has been proposed. Both
prostaglandin [1—41 and kinin [5—8] infusions lead to increased
salt and water excretion in the urine. Furthermore, the infusion
of bradykinin into the renal artery causes increased
prostaglandin release [9—121; while prostaglandin infusion in-
creases kallikrein release [13]. This linkage has been further
promoted by the finding that blockade of the prostaglandin
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system abolishes the effects of intravenous kinin infusions
[9—15]. However, other investigators have failed to demonstrate
this effect [16—21]. These conflicting studies are difilcult to
interpret because they have all been done in in vivo animal
preparations where both prostaglandins and kinins may have
many systemic effects which include alternations of renal
plasma flow, salt and water reabsorption [22, 23], and medullary
tonicity [241—all of which are known to be major determinants
of salt and water excretion. To measure the direct effects of
these substances on vasopressin-stimulated water transport, it
is helpful to study these questions in isolated tissues containing
vasopressin sensitive epithelia. Previously, we and others
[25—29] have examined the effect of the endogenous kallikrein-
kinin system in the toad urinary bladder, which is a model of the
distal nephron [30, 31]. By using the kallikrein inhibitor,
aprotinin [25, 26], and the kinin potentiator, captopril [32], we
found that the kallikrein-kinin system modulates vasopressin-
stimulated water and urea transport [25]. Similarly, prosta-
glandins have been shown to modulate vasopressin-stimulated
water transport in the toad bladder [33]. In the present study we
investigated whether the prostaglandin system and the
kallikrein-kinin system interact to modulate vasopressin-
stimulated water flow. We found that each system can exert its
effect independent of one another, suggesting that the two
systems modulate vasopressin action in different manners.
Methods
Female Dominican toads (National Diagnostics, Bridgeport,
Connecticut, USA) were doubly pithed; their hemibladders
were suspended in situ. The bladders were then excised and
washed three times with amphibian phosphate Ringer's solu-
tions (120 m sodium, 4 m'i potassium, 0.5 m calcium, 116
m chloride, 5 m phosphate, osmolality 240 mOsm/kg H20,
pH 7.4). The bladders were finally filled with 8 ml of buffered
distilled water (0.5 mM sodium phosphate, pH 7.4) and sus-
pended in a bath containing 35 ml of the Ringer's solution. Four
experimental pertubations were performed. Osmotic water flow
was measured gravimetrically [31, 35] for two 15-mm periods. A
comparison between control and experimental hemibladders
was performed by the paired t test.
Group 1. Endogenous prostaglandin production was abol-
ished by adding naproxen to the serosal bath of both hemiblad-
ders at a final concentration of i0- M. This concentration has
been shown to completely abolish endogenous prostaglandin
production [33]. In an additional study [34] naproxen 10—6 M
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inhibited prostaglandin production from 4.9 0.2 to 0.09
0.04 pmoles/min/hemibladder. Naproxen was allowed to
preincubate for 1 hr prior to the experiment. In the experimen-
tal hemibladder, aprotinin, a sereine protease inhibitor [25, 26]
was added to a concentration of 600 kallikrein inhibitory U/mi
(91 LM) to the mucosal solution. This dose has been shown to
inhibit a kallikrein-like material in the toad urinary bladder [25,
28]. Both the serosal and the mucosal solutions were allowed to
incubate for 1 hr. After a 1-hr incubation, the mucosal and
serosal solutions of both hemibladders were replaced with fresh
solutions of identical composition to remove any preformed
prostaglandins and/or kinins. The bladders were allowed to
equilibrate for 15 to 30 mm and an osmotic water flow was
determined at 15-mm intervals. After obtaining baseline water
flows, the response to vasopressin was measured.
Group 2. Bladders were handled similarly to group 1 in that
endogenous prostaglandins were inhibited with naproxen. An-
giotensin converting enzyme, captopril [25, 32], was added at a
concentration of 100 ig/ml to the experimental hemibladders.
This drug inhibits a kininase II enzyme in toad bladder. One
possible action is to potentiate endogenous kinins by blocking
their destruction. Similar to the group 1 hemibladders they were
allowed to incubate for 1 hr and both serosal and mucosal
solutions were replaced with identical solutions to remove
preformed prostaglandins and kinins. Baseline and vasopressin-
stimulated water flows were determined.
Group 3. In this group we examined the effect of inhibiting
the prostaglandin system when the endogenous kallikrein-kinin
system was similarly inhibited. To both hemibladders aprotinin
(600 KIU/ml) was added to the mucosal solution. To the
experimental hemibladder naproxen 10 M was added to the
serosal solution. After a 1-hr preincubation, both serosal and
mucosal solutions were replaced with identical solutions to
remove preformed kinins and prostaglandins. After a 15-mm
equilibration period osmotic water flow was measured during
basal and vasopressin-stimulated periods.
Group 4. In these group series we examined the effect of
exogenous prostaglandins added to the system when the kalli-
krein-kinin system had been inhibited. Again, to both
hemibladders aprotinin (600 KIU/ml) was added to the mucosal
solution. After a 1-hr preincubation, the serosal and mucosal
solutions were changed. In these experiments prostaglandin
PGE2 was added to the serosal solution at a concentration of
10-6 M. After a 15-mm incubation, the experiment was begun to
determine baseline and vasopressin-stimulated water flow.
In additional studies five toads were sacrificed. The
vasculature was perfused with buffered Ringer's solution to
remove blood from the system. Epithelial cells were scraped
into 1 ml of amphibian Ringer's solution containing 0.5%
sodium deoxycholate. Cells were broken with a Dounce homog-
enizer. Broken cells were allowed to incubate at 4°C for 1 hr.
Membranes were spun down at 8000 rpm and the supernatant
was saved. Bradykinin levels were measured in the supernatant
by RIA [36]. Supernatant was divided into twelve l00-d
aliquots. Six aliquots had 1 mg of captopril added. Five hundred
picograms of bradykinin were added to each aliquot and al-
lowed to incubate at 37°C for 30 mm. Five hundred picograms
of bradykinin were also added to twelve l00-d aliquots of
distilled water. One milligram of captopril was added to six
aliquots.
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Fig. 1. Effect of kallikrein inhibition (aprotinin) on vasopressin-
stimulated water flow (p.1/mm) when prostaglandins are inhibited(naproxen). C represents basal water flow while V represents
vasopressmn-stimulated water flow. Symbols are: E, naproxen; ,
naproxen plus aprotinin; *, P < 0.05. Vasopressin, 2 mU/ml, was
added serosally to each hemibladder.
Aprotinin was kindly provided in crystalline form by Dr. Gert
Haberland, Bayer Pharmaceuticals, Munich, West Germany,
and captopril was a gift of Dr. A. Hurovitz, E. R. Squibb &
Sons, Inc., Princeton, New Jersey, USA. Fresh solutions of
these compounds were prepared daily. Vasopressin was pur-
chased from Sigma Chemical Co., St. Louis, Missouri, USA.
Results
Group 1. In these experiments the endogenous kallikrein-
kinin system was inhibited in the experimental hemibladders in
the absence of prostaglandins. Vasopressin-stimulated water
flow increased from 34.8 6.1 to 38.3 5.3 p.11mm (P < 0.05,
Fig. 1). To see if the inhibition of vasopressin-stimulated water
flow occurred at maximum doses of vasopressin the same
protocol was used except that vasopressin was 25 mU/ml. In
this group vasopressin water flow increased from 24.8 4.9 to
34.5 4.8 p.11mm (P < 0.01, Fig. 2). Thus, inhibition of the
endogenous kallikrein-kinin system was able to significantly
increase vasopressin-stimulated water flow in the absence of
endogenous prostaglandins.
Group 2. In this group of animals captropril was used to
enhance endogenous kinins in the experimental hemibladders in
the absence of prostaglandins. Vasopressin-stimulated water
flow decreased from 45 6.3 to 30.5 5.4 p.11mm (P <0.05,
Fig. 3). Thus, enhancement of the endogenous kallikrein-kinin
system decreases vasopressin-stimulated water flow in the
absence of endogenous prostaglandins.
Group 3. In this group endogenous prostaglandins were
inhibited in the experimental hemibladders in the absence of an
endogenous kallikrein-kinin system. There was a significant
increase in vasopressin-stimulated water flow from 26.7 3.4
to 39.2 3.5 p.11mm (P < 0.02, Fig. 4). Thus, inhibition of the
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Fig. 2. Effect of kallikrein inhibition (aprotinin) on
vasopressin-stimulated water flow (MI/mm) when prostaglandins are
inhibited (naproxen). C represents basal water flow while V represents
vasopressin-stimulated water flow. Symbols are: fl, naproxen; ,
naproxen plus aprotinin; *, P < 0.01. Vasopressin, 25 mU/mi, was
added serosally to each hemibladder.
Fig. 3. Effect of kinin potentiation (captopril) on vasopressin-stimulated
water flow (pi/min) when prostaglandins are inhibited (naproxen). C
represents basal and V represents vasopressin-stimulated water flow.
Symbols are: D, naproxen; , naproxen plus captopril; *, P C 0.05.
Vasopressin, 2 mU/mi, was added serosally to each hemibladder.
endogenous prostaglandin system significantly increases vaso-
pressin-stimulated water flow in the absence of endogenous
kallikrein system.
Group 4. In this group exogenous prostaglandins were added
to the experimental hemibladders in the absence of an endogen-
ous kallikrein system. Vasopressin-stimulated water flow de-
creased from 17.5 2.7 to 5.7 l.0slImin(P <0.01, Fig. 5).
Thus, exogenous prostaglandins can inhibit vasopressin-
Fig. 4. Effect of prostaglandin inhibition (naproxen) on vasopressin-
stimulated water flow (ni/mm) when endogenous kallikrein is inhibited
(aprotinin). C represents basal while V represents vasopressin-
stimulated water flow. Symbols are: Q, aprotinin; , aprotinin plus
naproxen; sc, P c 0.02. Vasopressin, 2 mU/ml, was added serosally to
each hemibladder.
20 N=7
Fig. 5. Effect of PGE2 administration on vasopressin-stimulated water
flow when kallikrein is inhibited (aprotinin), C represents basal while V
represents vasopressin-stimulated water flow. Symbols are: 0,
aprotinin; ,aprotinin plus PGE2; *, P C 0.01. Vasopressin, 2 mU/ml,
was added serosally to each hemibladder.
stimulated water flow in the absence of an endogenous kal-
likrein system.
Homogenized toad bladder extract had no immunogenic
bradykinin present. Incubation of 500 pg of bradykinin and the
toad bladder at 37°C for 30 mm resulted in no measureable
bradykinin. Most likely bradykinin was rapidly degraded to
nonimmunogenic peptides by kininases present in the homogen-
ate. Pretreatment with captopril (1 mg) resulted in the recovery
of 313 45 pg of bradykinin (°°63% of added bradykinin).
Bradykinin added to distilled water and distilled water plus
captopril resulted in the recovery of 480 6 and 490 12 pg
of bradykinin, respectively.
Discussion
Prostaglandins and kinins have similar effects on vasopressin-
stimulated water flow. The findings that kinins increase prosta-
glandins production and prostaglandins increase kallikrein ex-
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work via a single mechanism to decrease vasopressin-
stimulated water flow.
Previously, we noted several differences between the
kallikrein-kinin system and the prostaglandin systems. For
instance, the kallikrein-kinin system acts at steps subsequent to
cyclic AMP generation [25], while the effect of prostaglandins
was believed to be at steps prior [31, 34] and subsequent [33] to
cyclic AMP generation. The kallikrein-kinin system depresses
vasopressin-stimulated water flow but increases vasopressin-
stimulated urea permeability [25]. By contrast, prostaglandins
decreased both vasopressin responsive transport processes
[31]. Since the two processes (water and urea transport) have
independent mechanisms at their final steps [35], one could still
argue that at least in terms of vasopressin-stimulated water
flow, kinins operate through prostaglandins, while they have a
direct effect on vasopressin-stimulated urea permeability. An-
other difference among the two systems is that the effects of
prostaglandins are greatest with submaximal vasopressin con-
centrations and can be overcome by maximal vasopressin
concentrations [31]. Quite opposite, the effects of the kallikrein-
kinin system are present with maximal and submaximal vaso-
pressin concentrations [25]. Although the body of the evidence
presented favors the two systems operating independent of one
another, one should nevertheless appreciate that the evidence is
indirect and hence no solid conclusions can be drawn. That was
indeed the reason why we undertook these present studies to
directly examine the interactions between the two systems.
Preliminary studies revealed that toad bladder homogenates
could destroy bradykinin and this process was partially blocked
by captopril. Previous studies [25, 26] showed that a kallikrein-
like enzyme is inhibited in toad skin and bladder homogenates
by aprotinin and naproxen inhibits endogenous prostaglandins.
In groups 1 and 2 the endogenous prostaglandin system
was inhibited by a prostaglandin synthetase inhibitor. In
group 1 inhibition of the kallikrein-kinin system by aprotinin
caused an increase in vasopressin-stimulated water flow. More
importantly, enhancement of the kallikrein-kinin system by
captopril (group 2) was able to decrease vasopressin-stimulated
water flow. The finding that the kallikrein-kinin system is fully
operative even when endogenous prostaglandin production is
abolished validates the hypothesis that the kallikrein-kinin
system is effective independent of the presence or absence of
prostaglandins.
Similarly, endogenous prostaglandin inhibition (group 3), and
exogenous prostaglandin addition (group 4) in the presence of
kallikrein inhibition was able to increase and decrease
vasopressin-stimulated water flow, respectively. This suggests
that the endogenous prostaglandin system works independent
of the kallikrein-kinin system.
The fact that prostaglandins and kinins act independent of
one another to decrease vasopressin-stimulated water flow in
the toad bladder does not exclude significant linkage of the two
systems; it simply suggests that one does not need the other to
exert its effects. The fact that they both modulate vasopressin
action and they increase or decrease in parallel in most situa-
tions suggests a close relationship. The fact that prostaglandins
are most effective at a low vasopressin concentration while
kinins operate even at a maximal one, taken together with their
independent action, may represent a significant homeostatic
mechanism. One could conceive that at low vasopressin con-
centrations, prostaglandins modulate vasopressin action pre-
cluding "overshoots" in response to the hormone. At higher
vasopressin concentrations where prostaglandin effects are
overcome, the epithelia activates the kallikrein-kinin system
which then modulates vasopressin action. If this hypothesis is
correct, then prostaglandins and kinins appear to operate in a
series, independent of one another but actually complementing
each other's action.
Reprint requests to Dr. G. Carvounis, Division of Nephrology and
Hypertension, State University of New York, Upstate Medical Center,
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